Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.38 |
| ▸ | RAB9A | P51151 | 5/20 | 0.38 |
| ▸ | CASP3 | P42574 | 2/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | NQO2 | P16083 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.36 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.36 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.36 |
| ▸ | KCNJ11 | Q14654 | 3/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.35 |
| ▸ | PLAU | P00749 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | PTGES | O14684 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7636705 | 0.83 | PTGES (0.33) | NPC1RAB9AGAAALDH1A1LMNA | |
| SCHEMBL7706993 | 0.82 | PTGES (0.37) | ALDH1A1LMNAPTGES | |
| SCHEMBL5437243 | 0.79 | KDM4E (0.41) | NPC1RAB9ACASP3SENP7TLR7 | |
| SCHEMBL5388347 | 0.78 | CASP3 (0.44) | NPC1RAB9ACASP3SENP7GAA | |
| SCHEMBL7963317 | 0.77 | RAB9A (0.34) | NPC1RAB9AGAAALDH1A1SMN1; SMN2 | |
| SCHEMBL7668209 | 0.71 | BCAT2 (0.32) | — | |
| SCHEMBL7657861 | 0.71 | BCAT2 (0.32) | — | |
| SCHEMBL7559209 | 0.70 | GRIN2D (0.38) | — | |
| SCHEMBL8682441 | 0.70 | — | — | |
| SCHEMBL8683761 | 0.69 | SMN1; SMN2 (0.34) | NPC1RAB9AALDH1A1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6455469-B1 | SUBSTITUTED ACETANILIDE DERIVATIVE IN COMBINATION WITH OTHER HERBICIDE TO GIVE EFFECTIVE WEED CONTORL | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2002-09-24 | — | — | US | disclosed |
| US-20020107148-A1 | Herbicidal composition | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2002-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020107148-A1 | Herbicidal composition | CPS1, HADHB, DDT | NPC1 4375/4885RAB9A 4404/4885CASP3 1822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.